Insights and Analysis
Hogan Lovells 2024 M&A Outlook
01 May 2024
Our 10th annual M&A Year in Review features a 2024 M&A Outlook, which provides insights across the key topics that we expect will influence dealmaking in the months to come:...
Publications
News
FTC finalizes rule banning non-compete agreements
25 April 2024
On April 23, 2024, the Federal Trade Commission (FTC) voted to publish a final rule that, effective 120 days after publication, will ban the use of non-compete clauses nationwide,...
News
Home truths: UK CMA wins in dispute over searches of domestic premises
25 April 2024
The UK High Court has ruled against the Competition Appeal Tribunal (“CAT”) in a case about the power of the Competition and Markets Authority (“CMA”) to search...
Insights and Analysis
Publication of the General Law on Adequate and Sustainable Food
23 April 2024
On April 17, 2024, the General Law of Adequate and Sustainable Food (the “Law”) was published on the Federal Official Gazette, whose principles and bases are aimed at protecting ...
Insights and Analysis
Publication of the General Law on Adequate and Sustainable Food
22 April 2024
On April 17, 2024, the General Law of Adequate and Sustainable Food (the “Law”) was published on the Federal Official Gazette, whose principles and bases are aimed at protecting ...
News
UK CMA publishes AI Foundation Models update paper
22 April 2024
The UK Competition and Markets Authority (“CMA”) has published an “Update Paper” outlining its evolving views on AI foundation models as well as its approach to...
News
FTC continues to highlight FDA Orange Book patent listings
05 April 2024
With the recent filing of an amicus brief in a private pharmaceutical patent infringement case, the Federal Trade Commission (FTC) has continued its focus on allegedly “improperly...
Insights and Analysis
Is Pay or Consent a choice under GDPR?
05 April 2024
Offering an alternative between payment and advertising is not per se contrary to the freedom of consent under the GDPR.
News
Commission investigation into termination of pipeline drug: what next for R&D decision-making?
02 April 2024
The European Commission has opened a formal investigation into whether Zoetis, a US animal health company, has acted in breach of the abuse of dominance rules by terminating development of...
